Document Detail


Chronic hepatitis C: retreatment of relapsers. An evidence-based approach.
MedLine Citation:
PMID:  10803635     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Post-treatment relapse remains a major issue in the long-term management of chronic hepatitis C. Many studies have been conducted to identify the ideal therapy that would increase the cost-effectiveness of retreatment in the individual patient. Although the conclusions of two consensus conferences for the retreatment of relapse of chronic hepatitis C have been published recently, several important issues still remain unanswered. We reviewed the available data by an evidence-based approach and conclude the following: (1) patients should be retreated with a combination of interferon (IFN) and ribavirin for 6 months if there are no contraindications to ribavirin; (2) the excellent tolerability and the lesser expense of retreatment with IFN monotherapy makes it a low-cost option for patients who have transiently cleared HCV-RNA during the first IFN course, and a primary indication for those who are contraindications to ribavirin or are likely to experience adverse events under ribavirin; (3) relapsers retreated with monotherapy must receive a high dose of IFN; and (4) patients with cirrhosis should not be retreated with IFN alone. More data, particularly on the long-term course of patients retreated with combination therapy, are needed before setting guidelines for retreatment of relapsers.
Authors:
C Cammà; A Craxì
Related Documents :
11468425 - Clinical, biologic, and behavioral predictors of early immunologic and virologic respon...
15580395 - Effect of single-dose administration of recombinant interferon-alpha2b on gastric myoel...
8314475 - High dose interferon treatment in chronic hepatitis c.
11283865 - A randomized trial of amantadine and interferon versus interferon alone as initial trea...
2006845 - Large skull defect in aplasia cutis congenita treated by pericranial flap: long-term fo...
8273855 - Impact of endoscopic therapy on outcome of operation for bleeding peptic ulcers.
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  Seminars in gastrointestinal disease     Volume:  11     ISSN:  1049-5118     ISO Abbreviation:  Semin. Gastrointest. Dis.     Publication Date:  2000 Apr 
Date Detail:
Created Date:  2000-07-18     Completed Date:  2000-07-18     Revised Date:  2005-11-16    
Medline Journal Info:
Nlm Unique ID:  9100391     Medline TA:  Semin Gastrointest Dis     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  115-21     Citation Subset:  IM    
Affiliation:
Istituto Metodologie Diagnostiche Avanzate, Consiglio Nazionale delle Ricerche, Palermo, Italy.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Antiviral Agents / administration & dosage*
Drug Therapy, Combination
Evidence-Based Medicine / methods*
Female
Hepatitis C, Chronic / diagnosis,  drug therapy*,  physiopathology
Humans
Interferons / administration & dosage*
Male
Prognosis
Recurrence
Retreatment
Severity of Illness Index
Treatment Outcome
Chemical
Reg. No./Substance:
0/Antiviral Agents; 9008-11-1/Interferons

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Hepatitis C virus and liver transplantation.
Next Document:  Brain imaging studies of cocaine abuse: implications for medication development.